Literature DB >> 24407049

Acute coronary syndrome among older patients: a review.

Murugapathy Veerasamy1, Richard Edwards, Gary Ford, Tom Kirkwood, Julia Newton, Dave Jones, Vijay Kunadian.   

Abstract

Ischemic heart disease is the leading cause of mortality worldwide. Due to advances in medicine in the past few decades, life expectancy has increased resulting in an aging population in developed and developing countries. Acute coronary syndrome causes greater morbidity and mortality in this group of older patients, which appears to be due to age-related comorbidities. This review examines the incidence and prevalence of acute coronary syndrome among older patients, examines current treatment strategies, and evaluates the predictors of adverse outcomes. In particular, the impact of frailty on outcomes and the need for frailty assessment in developing future research and management strategies among older patients are discussed.

Entities:  

Mesh:

Year:  2015        PMID: 24407049     DOI: 10.1097/CRD.0000000000000016

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  12 in total

1.  Five-year clinical outcomes in patients with frailty aged ≥75 years with non-ST elevation acute coronary syndrome undergoing invasive management.

Authors:  Hanna Ratcovich; Benjamin Beska; Greg Mills; Lene Holmvang; Jennifer Adams-Hall; Hannah Stevenson; Murugapathy Veerasamy; Chris Wilkinson; Vijay Kunadian
Journal:  Eur Heart J Open       Date:  2022-05-16

2.  Prognostic value of the C-reactive protein to albumin ratio in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

Authors:  Özgür Söğüt; Tarık Akdemir; Mehmet Mustafa Can
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

3.  Acute coronary syndrome in the older adults.

Authors:  Xuming Dai; Jan Busby-Whitehead; Karen P Alexander
Journal:  J Geriatr Cardiol       Date:  2016-02       Impact factor: 3.327

4.  Study to Improve Cardiovascular Outcomes in high-risk older patieNts (ICON1) with acute coronary syndrome: study design and protocol of a prospective observational study.

Authors:  Vijay Kunadian; R Dermot G Neely; Hannah Sinclair; Jonathan A Batty; Murugapathy Veerasamy; Gary A Ford; Weiliang Qiu
Journal:  BMJ Open       Date:  2016-08-23       Impact factor: 2.692

5.  Assessment of Intermingled Phlegm and Blood Stasis Syndrome in Coronary Heart Disease: Development of a Diagnostic Scale.

Authors:  Xuan Zhou; Xian-Tao Li; Xiao-Qi Liu; Bing Wang; Ge Fang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-24       Impact factor: 2.629

6.  The association of telomere length and telomerase activity with adverse outcomes in older patients with non-ST-elevation acute coronary syndrome.

Authors:  Danny Chan; Carmen Martin-Ruiz; Gabriele Saretzki; Dermot Neely; Weiliang Qiu; Vijay Kunadian
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

7.  A Quantitative Diagnostic Method for Phlegm and Blood Stasis Syndrome in Coronary Heart Disease Using Tongue, Face, and Pulse Indexes: An Exploratory Pilot Study.

Authors:  Qi Ren; Xiao-Wen Zhou; Mei-Ying He; Ge Fang; Bin Wang; Xin-Lin Chen; Xian-Tao Li
Journal:  J Altern Complement Med       Date:  2020-07-02       Impact factor: 2.579

8.  Frailty and quality of life in elderly patients with acute coronary syndrome.

Authors:  Magdalena Lisiak; Izabella Uchmanowicz; Radosław Wontor
Journal:  Clin Interv Aging       Date:  2016-05-05       Impact factor: 4.458

9.  Non-ST elevation acute coronary syndrome in patients aged 80 years or older in Vietnam: An observational study.

Authors:  Tan Van Nguyen; Khai Xuan Bui; Khuong Dang Tran; Duong Le; Tu Ngoc Nguyen
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

10.  Barthel Index as a Predictor of Mortality in Patients with Acute Coronary Syndrome: Better Activities of Daily Living, Better Prognosis.

Authors:  Fanghui Li; Dongze Li; Jing Yu; Yu Jia; Ying Jiang; Tengda Chen; Yongli Gao; Zhi Wan; Yu Cao; Zhi Zeng; Rui Zeng
Journal:  Clin Interv Aging       Date:  2020-10-13       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.